In 1982, the monoclonal antibody Ki-1 (later named TNFRSF8 or CD30) was highlighted when studying the Hodgkin and Reed–Sternberg cells of Hodgkin’s disease [16]. Here, TNFRSF8 is linked to Hodgkins lymphoma.